Friday, June 19, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 45 of 1,261
  1. US 12292441

    Recombinant Acinetobacter baumannii strain AB5075

    The Government of the United States, as represented by the Secretary of the Army · Granted May 6, 2025 · Expires May 1, 2045

    granted
  2. US 12291576

    Anti-CD45 antibodies and conjugates thereof

    Vor Biopharma Inc. · Granted May 6, 2025 · Expires May 1, 2045

    granted
  3. US 12290531

    Compositions targeting BCMA and methods of use thereof

    Takeda Pharmaceutical Company Limited · Granted May 6, 2025 · Expires May 1, 2045

    granted
  4. US 12290505

    Tissue factor-targeted antibody-drug conjugate

    SHANGHAI MIRACOGEN INC. · Granted May 6, 2025 · Expires May 1, 2045

    granted
  5. US 12291548

    Compounds, compositions, and methods for the treatment of disease

    Sperovie Biosciences, Inc. · Granted May 6, 2025 · Expires May 1, 2045

    granted
  6. US 12290524

    Methods and compositions for testosterone production

    Maximus Health, Inc. · Granted May 6, 2025 · Expires May 1, 2045

    granted
  7. WO 2025090898

    ANTICORPS ANTI-RÉCEPTEUR DE LA TRANSFERRINE ET LEURS UTILISATIONS - RÉFÉRENCES CROISÉES AUX DEMANDES CONNEXES

    BIOGEN MA INC [US] · Granted May 1, 2025 · Expires Apr 26, 2045

    granted
  8. WO 2025090858

    PROCÉDÉS D'IDENTIFICATION DE VARIANTS DE CAPSIDE DE VAA AYANT DES CARACTÉRISTIQUES SOUHAITÉES

    BIOGEN MA INC [US] · Granted May 1, 2025 · Expires Apr 26, 2045

    granted
  9. US 12285435

    Multivesicular liposome formulations of dexamethasone

    Pacira Pharmaceuticals, Inc. · Granted Apr 29, 2025 · Expires Apr 24, 2045

    granted
  10. US 12285392

    Method for modulating metabolism

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Apr 29, 2025 · Expires Apr 24, 2045

    granted
  11. US 12286406

    Inhibitors of receptor interacting protein kinase I for the treatment of disease

    The Board of Regents of the University of Texas System · Granted Apr 29, 2025 · Expires Apr 24, 2045

    granted
  12. US 12286456

    Purification of virus like particles

    Takeda Vaccines, Inc. · Granted Apr 29, 2025 · Expires Apr 24, 2045

    granted
  13. US 12285419

    Bupivacaine multivesicular liposome formulations and uses thereof

    Pacira Pharmaceuticals, Inc. · Granted Apr 29, 2025 · Expires Apr 24, 2045

    granted
  14. US 12285447

    Methods and compositions for treating ulcerative colitis

    Finch Therapeutics Holdings LLC · Granted Apr 29, 2025 · Expires Apr 24, 2045

    granted
  15. US 12285473

    Cancer vaccines targeting MUC16 and uses thereof

    Inovio Pharmaceuticals, Inc. · Granted Apr 29, 2025 · Expires Apr 24, 2045

    granted
  16. US 12285496

    Gene therapy for haploinsufficiency

    The Regents of the University of California · Granted Apr 29, 2025 · Expires Apr 24, 2045

    granted
  17. US 12285425

    Glucocorticoid receptor modulators to treat cervical cancer

    Corcept Therapeutics Incorporated · Granted Apr 29, 2025 · Expires Apr 24, 2045

    granted
  18. US 12286407

    Estrogen receptor beta ligands for the prevention and treatment of multiple sclerosis (MS) and other demyelinating, inflammatory and neurodegenerative diseases

    The Regents of the University of California · Granted Apr 29, 2025 · Expires Apr 24, 2045

    granted
  19. US 12285357

    Intraocular drug delivery systems and methods of use

    The Regents of the University of Colorado, a Body Corporate · Granted Apr 29, 2025 · Expires Apr 24, 2045

    granted
  20. US 12285460

    Pharmaceutical compositions

    RHYTHM PHARMACEUTICALS, INC. · Granted Apr 29, 2025 · Expires Apr 24, 2045

    granted
  21. US 12286657

    Methods and compositions

    United Kingdom Research and Innovation · Granted Apr 29, 2025 · Expires Apr 24, 2045

    granted
  22. US 12285478

    Foot-and-mouth disease vaccine

    United States of America as represented by the Secretary of the Air Force · Granted Apr 29, 2025 · Expires Apr 24, 2045

    granted
  23. US 12286479

    Treatment with anti-α4β7 antibody

    Takeda Pharmaceutical Company Limited · Granted Apr 29, 2025 · Expires Apr 24, 2045

    granted
  24. US 12285417

    Methods for treating chronic obstructive pulmonary disease

    Theravance Biopharma R&D IP, LLC · Granted Apr 29, 2025 · Expires Apr 24, 2045

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.